DJIA38904.04 307.06
S&P 5005204.34 57.13
NASDAQ16248.52 199.44
Russell 20002060.10 8.70
German DAX18163.94 -238.49
FTSE 1007911.16 -64.73
CAC 408061.31 -90.24
EuroStoxx 505013.35 -57.20
Nikkei 22538992.08 -781.06
Hang Seng16723.92 -1.18
Shanghai Comp3069.30 -5.66
KOSPI2714.21 -27.79
Bloomberg Comm IDX102.90 0.64
WTI Crude-fut91.17 0.01
Brent Crude-fut86.57 1.15
Natural Gas1.79 0.00
Gasoline-fut2.79 -0.01
Gold-fut2345.40 33.50
Silver-fut27.50 0.46
Platinum-fut940.60 -5.50
Palladium-fut1007.40 -23.60
Copper-fut423.60 1.85
Aluminum-spot1815.00 0.00
Coffee-fut212.50 5.75
Soybeans-fut1185.00 5.00
Wheat-fut567.25 11.00
Bitcoin67976.00 304.00
Ethereum USD3328.10 56.27
Litecoin98.71 0.69
Dogecoin0.18 0.00
EUR/USD1.0862 0.0007
USD/JPY151.72 -0.02
GBP/USD1.2678 0.0016
USD/CHF0.9044 -0.0014
USD IDX104.28 0.08
US 10-Yr TR4.4 0.091
GER 10-Yr TR2.406 0.007
UK 10-Yr TR4.064 -0.005
JAP 10-Yr TR0.771 -0.004
Fed Funds5.5 0
SOFR5.32 0

Sub Markets

Topics

Alternative Assets  + VC  | 
Aaron Rodgers’ RX3 Hauls $150M Catch from Athletes, Celebrities

Aaron Rodgers’ RX3 Hauls $150M Catch from Athletes, Celebrities

RX3 Growth Partners, the growth equity firm co-founded by four-time NFL MVP, Super Bowl champion and New York Jets quarterback Aaron Rodgers, Roth Capital Partners Chair & CEO Byron Roth, and Nate Raabe, the former managing director of Roth’s private capital group, has raised $150 million from athletes and celebrities to close its second fund.

NFL quarterbacks Josh Allen and Jared Goff invested in the fund alongside former Olympic swimmer Michael Phelps, as well as celebrities Miles Teller, Vanessa Hudgens, Machine Gun Kelly, Christina Aguilera, Marshmello and Thomas Rhett.

California-based RX3 typically invests in growth-oriented consumer companies with revenue of $10 million or more.

“This marks an exciting time for all of us at RX3,” said Rodgers. “Our family of athletes, musicians, actors and business leaders not only adds to the unique RX3 community we have built, but also allows us to invest in and support category leading growth-stage, consumer brands.”

Launched in 2018, RX3 typically invests alongside major private equity firms like L Catterton, TA Associates and TSG Consumer Partners, and it currently has 14 active investments, including stakes in Full Swing, Manscaped and Therabody.

RX3’s first fund was a $50 million vehicle that was fully deployed across 17 investments. That fund has posted a 62% IRR on four complete exits — telehealth provider Hims, pet food manufacturer Nom Nom, car care brand Chemical Guys and designer eyewear company Privé Revaux — and the partial exit of Orgain, which last year sold a majority stake to Nestle.

Connect

Inside The Story

RX3 Growth Partners

About Joe Palmisano

Joe Palmisano is Editorial Director for Connect Money, where he brings nearly three decades experience of market insights as a financial journalist, analyst and senior portfolio manager for leading financial publications, advisory firms, and hedge funds. In his role as Editorial Director, Joe is responsible for the selection of content and creation of daily business news covering the financial markets, including Alternative Assets, Direct Investment and Financial Advisory services. Before joining Connect Money, Joe was a financial journalist for the Wall Street Journal, regularly publishing feature stories and trend pieces on the foreign exchange, global fixed income and equity markets. Joe parlayed his experience as a financial journalist into roles as a Senior Research Analyst and Portfolio Manager, writing daily and weekly market analysis and managing a FX and US equity portfolio. Joe was also a contributing writer for industry magazines and publications, including SFO Magazine and the CMT Association. Joe earned a B.S.B.A. in Finance from The American University. He holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.

New call-to-action